GRDX earnings: next report 2026-08-17, real EPS beat/miss history, analyst consensus Buy, P/E -0.73. Updated 2026-07-23.
GridAI Technologies (GRDX) Research Hub
GridAI Technologies (GRDX) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.86 USD (-5.30%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.73, market cap 0.01B. This hub links to the full technical, earnings and options research available for GRDX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.86 USD (-5.30%) |
| 52-week range | 2.56 USD – 5.69 USD |
| Trend regime | Range |
| 14-day RSI | 51.6 (Neutral) |
| Trailing P/E | -0.73 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-17 |
Available research for GRDX
Covered Call on GRDX: how it works, illustrative setup around the real 2.86 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GRDX: how it works, illustrative setup around the real 2.86 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GRDX: how it works, illustrative setup around the real 2.86 USD price, max profit/loss, breakeven and when to use it. Educational.
GRDX technical analysis: range, last 2.86 USD, RSI 51.6, 52w range 2.56 USD–5.69 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is GRDX in?
GridAI Technologies (GRDX) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is GRDX in an uptrend or downtrend?
As of 2026-09-11, GRDX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GRDX's trailing P/E ratio?
GRDX's trailing P/E is -0.73, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does GRDX next report earnings?
GRDX is next scheduled to report earnings on 2026-08-17, with a consensus EPS estimate of -9,450 USD.